RTH258A
Drug
Novartis Pharma AG
Total Payments
$56,535
Transactions
135
Doctors
61
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $11,410 | 82 | 23 |
| 2017 | $45,125 | 53 | 40 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $41,820 | 8 | 74.0% |
| Food and Beverage | $6,919 | 81 | 12.2% |
| Travel and Lodging | $5,276 | 45 | 9.3% |
| Unspecified | $2,520 | 1 | 4.5% |
Payments by Type
General
$54,015
134 transactions
Research
$2,520
1 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| OUTCOMES RESEARCH | NOVARTIS PHARMACEUTICALS CORPORATION | $2,520 | 1 |
Top Doctors Receiving Payments for RTH258A
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Ophthalmology | Baltimore, MD | $6,918 | 2 |
| , MD | Ophthalmology | Clearwater, FL | $6,210 | 3 |
| , M.D | Ophthalmology | Chesterfield, MO | $5,805 | 3 |
| , MD | Ophthalmology | Cleveland, OH | $5,746 | 2 |
| , MD | Ophthalmology | Los Angeles, CA | $5,710 | 1 |
| , MD | Ophthalmology | Stanford, CA | $5,107 | 3 |
| , M.D | Ophthalmology | Durham, NC | $3,912 | 3 |
| , MD | Ophthalmology | Plymouth Meeting, PA | $3,710 | 1 |
| , MD | Ophthalmology | Harvey, IL | $2,520 | 1 |
| , M.D | Internal Medicine | Boston, MA | $662.13 | 5 |
| , MD | Retina Specialist | Austin, TX | $600.35 | 4 |
| , M.D | Ophthalmology | San Antonio, TX | $569.45 | 5 |
| , MD | Ophthalmology | Mountain View, CA | $548.78 | 6 |
| , M.D | Ophthalmology | Reno, NV | $484.51 | 5 |
| , MD | Retina Specialist | Rochester, MN | $476.84 | 5 |
| , M.D | Ophthalmology | Austin, TX | $463.15 | 3 |
| , MD | Ophthalmology | Riverside, CA | $462.07 | 6 |
| , MD | Retina Specialist | Boston, MA | $443.42 | 4 |
| , M.D | Ophthalmology | Phoenix, AZ | $411.08 | 5 |
| Pravin Dugel | Ophthalmology | Phoenix, AZ | $407.56 | 4 |
| , M.D | Ophthalmology | Boston, MA | $388.39 | 4 |
| , MD | Ophthalmology | Marietta, GA | $384.54 | 4 |
| , M.D | Ophthalmology | Boston, MA | $370.50 | 2 |
| , MD | Ophthalmology | Miami, FL | $365.95 | 3 |
| , MD | Ophthalmology | Denver, CO | $365.95 | 3 |
Ad
Manufacturing Companies
- Novartis Pharma AG $45,125
- Novartis Pharmaceuticals Corporation $8,890
- NOVARTIS PHARMACEUTICALS CORPORATION $2,520
Product Information
- Type Drug
- Total Payments $56,535
- Total Doctors 61
- Transactions 135
About RTH258A
RTH258A is a drug associated with $56,535 in payments to 61 healthcare providers, recorded across 135 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharma AG.
Payment data is available from 2017 to 2018. In 2018, $11,410 was paid across 82 transactions to 23 doctors.
The most common payment nature for RTH258A is "Consulting Fee" ($41,820, 74.0% of total).
RTH258A is associated with 1 research study, including "OUTCOMES RESEARCH" ($2,520).